You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

childhood acute myeloid leukemia in remission

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

Recruiting
  • Acute Myeloid Leukemia
  • Beijing, Beijing, China
    Peking University People's Hospital
Jun 23, 2023

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting
  • AML
  • +11 more
  • (no location specified)
Aug 14, 2023

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding

Completed
  • Leukemia, Acute
    • (no location specified)
    Jul 23, 2023

    AML Trial in Guanzhou (CLAG)

    Not yet recruiting
    • AML
    • CLAG
    • Guanzhou, Guangdong, China
    • +1 more
    May 16, 2023

    Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Lyon, France
      Centre Léon Bérard
    Nov 30, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • (no location specified)
    May 29, 2023

    Leukemia, Myeloid, Acute Trial in Seoul (Idarubicin)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Seoul, Korea, Republic of
      Division of Hematology-Oncology, Konkuk University Medical Cente
    Apr 8, 2022

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jul 1, 2023

    Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)

    Recruiting
    • Acute Myeloid Leukemia
    • Decitabine and Cedazuridine
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 10, 2022

    Acute Myeloid Leukemia Trial (ABBV-787)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 29, 2023

    Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

    Not yet recruiting
    • Chemotherapy-Induced Thrombocytopenia
    • Hetrombopag Olamine
    • (no location specified)
    Jul 5, 2023

    Acute Lymphoid Leukemia, Acute Myeloid Leukemia in Children Trial in Tours (Biological sampling in patients, Biological sampling

    Not yet recruiting
    • Acute Lymphoid Leukemia
    • Acute Myeloid Leukemia in Children
    • Biological sampling in patients
    • Biological sampling in control patients
    • Tours, France
    • +2 more
    Mar 17, 2023

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • Acute Myeloid Leukemia Refractory
    • (no location specified)
    Nov 9, 2023

    Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jul 21, 2023

    Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

    Not yet recruiting
    • Leukemia
    • +12 more
    • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
    • (no location specified)
    Mar 20, 2023

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Blasts Under

    Active, not recruiting
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • +3 more
    • Laboratory Biomarker Analysis
    • Nivolumab
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 10, 2022

    PET Tracer Based FDG Signal for Predicting Prognosis in Acute

    Enrolling by invitation
    • Acute Myeloid Leukemia
    • No intervention
    • Guangzhou, Guangdong, China
      First Affiliated Hospital of Jinan University
    Jun 22, 2023

    Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

    Recruiting
    • Refractory/Relapse Acute Myeloid Leukemia
    • Kunming, Yunnan, China
      Department of Hematology,920th Hospital of Joint Logistic Suppor
    Mar 28, 2023

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • +2 more
    • CPI 613
    • +3 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    May 10, 2023

    Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Suzhou, Jiangsu, China
      Qiu Huiying
    Mar 28, 2023

    A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

    Not yet recruiting
    • C-KIT Mutation
      • (no location specified)
      Nov 2, 2023

      Acute Myeloid Leukemia Trial in Suzhou (Venetoclax Oral Tablet, Daunorubicin)

      Recruiting
      • Acute Myeloid Leukemia
      • Suzhou, Jiangsu, China
      • +1 more
      Jul 3, 2023

      Acute Myeloid Leukemia Trial in Worldwide (Cyclophosphamide-Fludarabine (Cy/Flu), oNKord®)

      Recruiting
      • Acute Myeloid Leukemia
      • Cyclophosphamide-Fludarabine (Cy/Flu)
      • oNKord®
      • Ghent, Belgium
      • +9 more
      Jun 15, 2022